Increased expression of nucleolar and spindle-associated protein 1 (NUSAP1) has been identified as a robust clinical biomarker of aggressive prostate cancer and is part of two commercial prognostic gene expression panels used to analyze prostate tissue samples [2,3,4,5]. The gene discussed is NUSAP1; the disease is Familial prostate cancer.